Relation between the action of dopamine and apomorphine and their O-methylated derivatives upon the CNS.
D000478:Alkylation; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology*; D001522:Behavior, Animal; D001923:Brain Chemistry; D002490:Central Nervous System / Q000187:drug effects*; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism / Q000494:pharmacology*; D007490:Iproniazid / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D014443:Tyrosine / Q000494:pharmacology
D010627:Phenethylamines; D014443:Tyrosine; D004295:Dihydroxyphenylalanine; D007490:Iproniazid; D001058:Apomorphine; D004298:Dopamine
Science. 1958 Feb 28;127(3296):471
13529006
Pharmacol Rev. 1959 Jun;11(2, Part 2):317-29
13667412
Pharmacol Rev. 1959 Jun;11(2, Part 2):490-3
13667431
Experientia. 1959 Oct 15;15:382-4
13799996
Rev Can Biol. 1961 Jun;20:197-203
13864824
Wien Klin Wochenschr. 1961 Nov 10;73:787-8
13869404
Acta Physiol Pharmacol Neerl. 1962;11:48-53
13890651
Nature. 1962 Jan 13;193:178-9
13890652
Wien Z Nervenheilkd Grenzgeb. 1962;20:90-100
13947380
Int J Neuropharmacol. 1964 May;3:227-39
14336531
Klin Wochenschr. 1960 Jan 15;38:57-62
14441534
Psychopharmacologia. 1965 May 21;7(6):383-90
5890661